What is the dosing for Amoxicillin-Clavulanate (Amoxy-Clav) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing in Pediatric Patients

For pediatric patients aged 3 months and older, amoxicillin-clavulanate should be dosed at 45 mg/kg/day (based on amoxicillin component) divided twice daily for mild-moderate infections, and 90 mg/kg/day divided twice daily for severe infections, with a maximum of 2 g per dose. 1

Age-Based Dosing Recommendations

Neonates and Infants <12 weeks (<3 months)

  • 30 mg/kg/day of amoxicillin component divided every 12 hours 2
  • Use 125 mg/5 mL oral suspension for this age group 2

Infants and Children 12 weeks (3 months) and Older

  • Mild/moderate infections: 25 mg/kg/day divided every 12 hours (or 20 mg/kg/day divided every 8 hours) 2
  • Severe infections, otitis media, sinusitis, lower respiratory tract infections: 45 mg/kg/day divided every 12 hours (or 40 mg/kg/day divided every 8 hours) 2
  • For patients with risk factors for resistant organisms: 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses 1

Children Weighing ≥40 kg

  • Should be dosed according to adult recommendations 2
  • The 250 mg/125 mg tablets should not be used until the child weighs at least 40 kg due to different amoxicillin-to-clavulanate ratios 2

Risk Factors for Resistant Organisms

Higher dosing (90 mg/kg/day) is recommended for patients with:

  • Age younger than 2 years 1
  • Attendance at childcare 1
  • Recent antimicrobial treatment (within previous 30 days) 1
  • Moderate to severe illness 1
  • Areas with high prevalence of nonsusceptible S. pneumoniae (>10%) 1

Formulation Considerations

  • The 12-hour regimen is recommended as it is associated with significantly less diarrhea 2
  • The pediatric formulation provides a 14:1 ratio of amoxicillin to clavulanate in an oral suspension 1
  • For children who cannot tolerate oral medication, a single 50 mg/kg dose of ceftriaxone can be given intravenously or intramuscularly 1

Duration of Therapy

  • Treatment should continue for a minimum of 48-72 hours beyond the time that the patient becomes asymptomatic 3
  • For streptococcal infections, at least 10 days of treatment is recommended to prevent acute rheumatic fever 3
  • For acute otitis media, 10 days of therapy is recommended 2

Special Considerations

Renal Impairment

  • Patients with impaired renal function generally do not require dose reduction unless impairment is severe 2
  • For severe impairment (GFR <30 mL/min), avoid the 875 mg/125 mg dose 2

Administration

  • To minimize gastrointestinal intolerance, amoxicillin-clavulanate should be taken at the start of a meal 2, 3
  • Shake oral suspension well before using 3

Common Pitfalls and Caveats

  1. Dosing confusion: The twice-daily regimen is preferred over three times daily due to better compliance and fewer gastrointestinal side effects 4

  2. Formulation differences: Different formulations have different amoxicillin-to-clavulanate ratios. The 250 mg/125 mg tablet and the 250 mg/62.5 mg chewable tablet are not interchangeable 2

  3. Weight-based dosing: Always calculate dose based on body weight rather than age for more accurate dosing 5

  4. Prescription clarity: Include on the prescription: daily dose, number of divided doses, duration of therapy, indication, and child's weight 5

  5. Storage of suspension: After reconstitution, any unused portion must be discarded after 14 days. Refrigeration is preferable but not required 3

By following these evidence-based dosing recommendations, clinicians can optimize treatment outcomes while minimizing adverse effects in pediatric patients requiring amoxicillin-clavulanate therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.